Evidence map›Paper›PMID 38229890›Full record

ArticleJournal of clinical and translational science2023

The Trial Innovation Network Liaison Team: building a national clinical and translational community of practice.

Marisha E Palm, Dixie D Thompson, Terri Edwards, Kitt Swartz, Keith A Herzog, Shweta Bansal, Benjamin Echalier, Kristen Clasen DeHart, Signe Denmark, Jurran L Wilson and 10 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical and translational science, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 10 institutions in 1 country.

Marisha E PalmTufts Medical Center, Boston, MA, USA.ORCID https://orcid.org/0000-0002-9760-7196
Dixie D ThompsonClinical & Translational Science Institute, University of Utah School of Medicine, Salt Lake City, UT, USA.ORCID https://orcid.org/0000-0002-7314-9303
Terri EdwardsVanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center, Nashville, TN, USA.
Kitt SwartzOregon Clinical and Translational Research Institute, Oregon Health & Science University, Portland, OR, USA.
Keith A HerzogNorthwestern University Clinical and Translational Science Institute, Chicago, IL, USA.
Shweta BansalUniversity of Texas Health Science Center, San Antonio, TX, USA.ORCID https://orcid.org/0000-0002-3306-2799
Benjamin EchalierUniversity of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Kristen Clasen DeHartMedical University of South Carolina, Charleston, SC, USA.
Signe DenmarkMedical University of South Carolina, Charleston, SC, USA.
Jurran L WilsonClinical and Translational Science Institute at Children's National Hospital, Children's National Hospital, Washington, DC, USA.ORCID https://orcid.org/0000-0001-6926-8644
Sarah NelsonVanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center, Nashville, TN, USA.
Salina P WaddyDivision of Clinical Innovation, National Center for Advancing Translational Sciences, Bethesda, MD, USA.
Sarah E DunsmoreDivision of Clinical Innovation, National Center for Advancing Translational Sciences, Bethesda, MD, USA.
Jane C AtkinsonDivision of Clinical Innovation, National Center for Advancing Translational Sciences, Bethesda, MD, USA.
Ken WileyDivision of Clinical Innovation, National Center for Advancing Translational Sciences, Bethesda, MD, USA.
Sara HassaniDivision of Clinical Innovation, National Center for Advancing Translational Sciences, Bethesda, MD, USA.
Jamie P DwyerClinical & Translational Science Institute, University of Utah School of Medicine, Salt Lake City, UT, USA.
Daniel F HanleyAcute Care Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID https://orcid.org/0000-0002-9536-4258
J Michael DeanClinical & Translational Science Institute, University of Utah School of Medicine, Salt Lake City, UT, USA.
Daniel E FordInstitute for Clinical and Translational Research, Johns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID https://orcid.org/0000-0002-2549-2289
National Center for Advancing Translational Sciences · USUniversity of Utah · USJohns Hopkins University · USMedical University of South Carolina · USVanderbilt University Medical Center · USNorthwestern University · USOregon Health & Science University · USThe University of Texas Health Science Center at San Antonio · USTufts Medical Center · USUniversity of Colorado Anschutz Medical Campus · US

Funding

Utah Trial Innovation CenterU24TR001597 · NCATS · UNIVERSITY OF UTAH · PI DEAN, JONATHAN MICHAEL · 2016 to 2022
$39.6M
CTSA UM1 Program at University of UtahUM1TR004409 · NCATS · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI RACHEL HESS, Jennifer Juhl Majersik · 2023 to 2026
$21.9M
NCATS NIH HHS U24 TR001597NCATS NIH HHS UM1 TR004409
6 · The paper itself

Abstract

In 2016, the National Center for Advancing Translational Science launched the Trial Innovation Network (TIN) to address barriers to efficient and informative multicenter trials. The TIN provides a national platform, working in partnership with 60+ Clinical and Translational Science Award (CTSA) hubs across the country to support the design and conduct of successful multicenter trials. A dedicated Hub Liaison Team (HLT) was established within each CTSA to facilitate connection between the hubs and the newly launched Trial and Recruitment Innovation Centers. Each HLT serves as an expert intermediary, connecting CTSA Hub investigators with TIN support, and connecting TIN research teams with potential multicenter trial site investigators. The cross-consortium Liaison Team network was developed during the first TIN funding cycle, and it is now a mature national network at the cutting edge of team science in clinical and translational research. The CTSA-based HLT structures and the external network structure have been developed in collaborative and iterative ways, with methods for shared learning and continuous process improvement. In this paper, we review the structure, function, and development of the Liaison Team network, discuss lessons learned during the first TIN funding cycle, and outline a path toward further network maturity.

Indexed as

clinical trialscollaborationcommunity of practiceCTSAteam scienceTrial Innovation Network

Identifiers

PMID38229890
PMCPMC10790104
OpenAlexW4388414689

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.